The mutations that drive cancer. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

Similar documents
Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

Oncogenes and Tumor. supressors

Introduction to Cancer Biology

oncogenes-and- tumour-suppressor-genes)

Molecular Cell Biology. Prof. D. Karunagaran. Department of Biotechnology. Indian Institute of Technology Madras

Determination Differentiation. determinated precursor specialized cell

Overview of the core ideas in cancer research

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber

Prof. R. V. Skibbens

number Done by Corrected by Doctor Maha Shomaf

Development of Carcinoma Pathways

609G: Concepts of Cancer Genetics and Treatments (3 credits)

Lecture 8 Neoplasia II. Dr. Nabila Hamdi MD, PhD

Neoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath

VIII Curso Internacional del PIRRECV. Some molecular mechanisms of cancer

Emerging" hallmarks of cancer, a. Reprogramming of energy metabolism b. Evasion of the immune system, Enabling characteristics, a.

Deregulation of signal transduction and cell cycle in Cancer

Diagnostic test Suggested website label Description Hospitals available

Cancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?

Mohammed El-Khateeb. Tumor Genetics. MGL-12 May 13 th Chapter 22 slide 1 台大農藝系遺傳學

MOLECULAR BASIS OF ONCOGENESIS

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

Section D. Genes whose Mutation can lead to Initiation

Molecular biology :- Cancer genetics lecture 11

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Biology of cancer development in the GI tract

COPYRIGHTED MATERIAL. An Introduction to Cancer Cell Biology and Genetics CHAPTER 1 IN BRIEF 1.1 INTRODUCTION

Section D: The Molecular Biology of Cancer

Cancer genetics

RAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX

Neoplasia 2018 lecture 4. Dr Heyam Awad MD, FRCPath

Prof. R. V. Skibbens. Cell Cycle, Cell Division and Cancer (Part 2)

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)

Present State of Gene Diagnosis and Future Prospects

BCHM3972 Human Molecular Cell Biology (Advanced) 2013 Course University of Sydney

Genetics of Cancer Lecture 32 Cancer II. Prof. Bevin Engelward, MIT Biological Engineering Department

TUMOR-SUPPRESSOR GENES. Molecular Oncology Michael Lea

Genomic Instability. Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute. RPN-530 Oncology for Scientist-I October 18, 2016

Out-Patient Billing CPT Codes

Multistep nature of cancer development. Cancer genes

Colon Cancer and Hereditary Cancer Syndromes

CELL CYCLE REGULATION AND CANCER. Cellular Reproduction II

Genomic instability. Amin Mahpour

THE HALLMARKS OF CANCER

Genomic analysis of childhood High grade glial (HGG) brain tumors

Chapter 18- Oncogenes, tumor suppressors & Cancer

Cell cycle, signaling to cell cycle, and molecular basis of oncogenesis

Principles of Genetics and Molecular Biology

Activation of cellular proto-oncogenes to oncogenes. How was active Ras identified?

Osamu Tetsu, MD, PhD Associate Professor Department of Otolaryngology-Head and Neck Surgery School of Medicine, University of California, San

Tumor suppressor genes D R. S H O S S E I N I - A S L

Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making

Mohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Chapt 15: Molecular Genetics of Cell Cycle and Cancer

Cell Cycle and Cancer

Molecular biology of colorectal cancer

Molecular Oncology, oncology parameters see each test

A class of genes that normally suppress cell proliferation. p53 and Rb..ect. suppressor gene products can release cells. hyperproliferation.

Variations in Chromosome Structure & Function. Ch. 8

Genomic Medicine: What every pathologist needs to know

Role of FISH in Hematological Cancers

CELL CYCLE MOLECULAR BASIS OF ONCOGENESIS

p53 and Apoptosis: Master Guardian and Executioner Part 2

Basic tumor nomenclature

Genetics and Cancer Ch 20

KRAS: ONE ACTOR, MANY POTENTIAL ROLES IN DIAGNOSIS

BIO360 Fall 2013 Quiz 1

Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture:

Molecular Markers in Acute Leukemia. Dr Muhd Zanapiah Zakaria Hospital Ampang

Plasma-Seq conducted with blood from male individuals without cancer.

Chapter 4 Cellular Oncogenes ~ 4.6 -

Chapter 16 Mutations. Practice Questions:

Current and future applications of Molecular Pathology. Kathy Walsh Clinical Scientist NHS Lothian

BIO360 Quiz #1. September 14, Name five of the six Hallmarks of Cancer (not emerging hallmarks or enabling characteristics ): (5 points)

Introduction to Genetics

Introduction to Cancer Bioinformatics and cancer biology. Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015

C) The graph should look exactly like the graph on the left (Mut1 cells + Mating Pheromone for 3 hours at 25 degrees). The cells arrest in G1.

Genetics and Genomics in Medicine Chapter 10. Questions & Answers

Targeted therapy & Tumor molecular profile. Anton Tikhonov V Bioinformatics Summer School, 2017

Test Name Results Units Bio. Ref. Interval. Positive

Dr C K Kwan. Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK

Origin of oncogenes? Oncogenes and Proto-oncogenes. Jekyll and Hyde. Oncogene hypothesis. Retroviral oncogenes and cell proto-oncogenes

Signaling. Dr. Sujata Persad Katz Group Centre for Pharmacy & Health research

Oncogenes and tumour suppressor genes

SureSelect Cancer All-In-One Custom and Catalog NGS Assays

The Pathology of Neoplasia Part II

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007

Multistep Carcinogenesis

EGFR: fundamenteel en klinisch

Colon cancer: practical molecular diagnostics. Wade S. Samowitz, M.D. University of Utah and ARUP

MSI positive MSI negative

A. Incorrect! All the cells have the same set of genes. (D)Because different types of cells have different types of transcriptional factors.

STRUCTURAL CHROMOSOMAL ABERRATIONS

Glioblastoma pathophysiology: or a

Transcription:

The mutations that drive cancer Paul Edwards Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

Previously on Cancer... hereditary predisposition Normal Cell Slightly Abnormal More Abnormal Malignant? Gene changes mutations + epigenetic change + viruses + mobile elements accelerated by Genetic Instability

Which genes are altered in cancer? - all sorts of different pathways and systems - Mitogenic signalling pathways e.g. Wnt signalling pathway*, Receptor tyrosine kinase pathways* Rb control of cell cycle Hedgehog pathway, Notch pathway, Hippo pathway... - Inhibitory signalling, e.g. TGF-β pathway* - Transcription control systems - transcription factors - p53 - beta-catenin, MYC and ETS families - hormone receptors ER - chromatin / histone modifiers - Cell adhesion, e.g. cadherin E in breast - telomerase - DNA repair and mitotic processes - Carbohydrate metabolism (IDH1 in gliomas and AML) - etc., etc.!

A weird example

citric acid cycle citrate A weird example isocitrate isocitrate dehydrogenases hydroxyglutarate alphaketoglutarate DNA hypermethylation? = epigenetic instability? isocitrate dehydrogenase IDH1 mutated in majority glioblastomas, occasional leukaemias,

What sorts of mutations alter the genes? All sorts of mutation

What sorts of mutations alter the genes? Sequence changes, e.g. TCGAGCTATGTGTCTCTAGGTCGGT TCGAGCTATGAGTCTCTAGGTCGGT Small-scale changes STRUCTURAL changes, e.g. Large-scale changes

What sorts of mutations alter the genes? - single base pair change, e.g. RAS, p53... Small-scale changes - chromosome translocation - Amplification (lot of copies of gene) - Duplication - Deletion Large-scale changes

What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift Small-scale changes - chromosome translocation APC classic example, truncated in colon - Amplification (lot of copies of gene) - Duplication - Deletion Large-scale changes

What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift Small-scale changes - chromosome translocation APC classic example, truncated in colon - Amplification (lot of copies of gene) - Duplication - Deletion Large-scale changes

What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift Small-scale changes - chromosome translocation APC classic example, truncated in colon, first mutation in Vogelstein s model of colon cancer, - Amplification (lot of copies of gene) - Duplication - Deletion Large-scale changes

Deleting the APC gene in colon Wild-type APC deleted Crypt region Sansom, O.J. et al., 2004. Genes & development Crypt region has expanded

What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift Small-scale changes - chromosome translocation...cca ATA AAT TAT AGT...... P I N Y S... - Amplification (lot of copies of gene) - Duplication...CCA ATA AAT TTA TAG...... P I N L *STOP - Deletion APC classic example, truncated in colon T truncated APC protein Large-scale changes

What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift - (e.g. APC in practical) Small-scale changes - Deletion - Inversion - Duplication - Amplification - Chromosome translocation Large-scale changes

Duplication and amplification Gene e.g. EGFR Duplication tandem OR inverted Amplification Amplified gene

Chromosome translocation reciprocal translocation OR unbalanced translocation

Chromosome translocation translocation beginning of gene A end of gene B

What sorts of mutations alter the genes? How do we study these mutations?

How did we discover cancer genes historically before large scale sequencing Viruses: retrovirus oncogenes e.g. RAS, MYC (RAt Sarcoma, MYeloblastosis C) DNA tumour viruses p53 - Deletion Hereditary predisposition to cancer - Duplication e.g. breast cancer prediposition BRCA1, BRCA2 polyposis coli APC - Amplification (lot of copies of gene) Large-scale changes - Chromosome translocation

p53 is a hub for stress signalling DNA damage telomeres short aberrant growth signals ATM, ATR kinases (inhibits CDK/cyclin complexes) p21 p53 p53 p53 p53 p14 ARF DNA Viruses: e.g. HPV AdenoV RB pathway cycle arrest apoptosis

How do we study the alterations/mutations? sequencing Small-scale changes - Deletion - Duplication - Amplification (lot of copies of gene) Large-scale changes - Chromosome translocation

Passengers versus Drivers Normal Cell Slightly Abnormal More Abnormal Malignant A AB ABC ABCD Gene changes

Passengers versus Drivers Normal Cell Slightly Abnormal More Abnormal Malignant Random passenger mutations X Y A XY Y AB Z ABC XY X ABCD Z α γα γα β Z Gene changes random passenger mutations are difficult to distinguish from driver mutations

How do we study the alterations/mutations? sequencing Small-scale changes - Deletion started with cytogenetics... - Inversion - Duplication Large-scale changes - Amplification - Chromosome translocation

Metaphase chromosomes

Karyotype

Philadelphia chromosome 9:22 22:9

Breast Cancer Karyotype, from primary culture Pandis et al (1998) Genes Chromosomes Cancer 22, 122

Amplification of N-MYC Chr 12 * One copy N-MYC Hundreds of copies

Breast Cancer Cell Line MDA-MB-361 Joanne Davidson

CGH Hybridization: Search for deletions and amplifications Amplification EGFreceptor (ERBB/ HER-1) Number of copies 2 1 0 Genome position glioblastoma Deletion P16/CDKN2A/INK4A implicated in senescence

Examples of mutations Tyrosine kinases and signalling downstream from them

Receptor Tyrosine Kinase (RTK) signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor / ERBB, HER-1 PIP2/ PI3KCA PIP3 AKT ERBB2/HER-2 PTEN tyrosine kinases

POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor A.k.a ERBB, HER-1 Ras GTP (ac,ve) PI3KCA PIP3 AKT SOS PTEN GAP ERBB2/HER-2 Ras GDP (inac,ve)

POINT Mutations in RTK signalling pathways EGF EGF-Receptor RAS Grb2, SoS B-RAF RAS family: HRAS, KRAS, NRAS MAP Kinase pathway PI3KCA PIP3 AKT ERBB2/HER-2 PTEN

POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA ERBB2/HER-2 - Activating mutations, act like ras mutations. PIP3K AKT - In tumours that otherwise have Ras PTEN mutations e.g. 60% of melanomas, some colon cancers - Commonest mutation V600E (valine 600 -> glutamic acid),

BRAF V600E activation valine glutamic acid V600 595 594 598 596 T599 Activation segment is thought to move when Thr599 is phosphorylated, activating kinase. V600E where valine replaced by Gutamic acid doesn t need phosphorylation. Wan et al, 2004 PMID 15035987

POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA ERBB2/HER-2 notes: PIP3 AKT activating mutations are highlyspecific PTEN pathways mutated rather than genes

POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA ERBB2/HER-2 - Activating mutations. - One PIP3K of the Common AKT mutations - E542K (glutamic acid 542 -> lysine) PTEN - 40% of breast cancers, several other cancers

POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA PIP3 AKT PTEN ERBB2/HER-2 Both occasionally point mutated in lung cancers

POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA PIP3 AKT ERBB2/HER-2 PTEN

POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA PIP3 PTEN AKT ERBB2/HER-2 RAS, RAF and PI3KCA feature in Vogelstein s model of colon cancer

Examples of alterations/mutations? - single base pair change - Indel = Small insert or deletion Small-scale changes - Deletion - Inversion - Duplication - Amplification - Chromosome translocation Large-scale changes

Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA PIP3 AKT PTEN ERBB2/HER-2 Deletions common (as well as point mutations)

What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion -> Small-scale changes - Deletion - Inversion - Duplication - Amplification - Chromosome translocation Large-scale changes

Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor Activated by tandem duplication! PI3KCA PIP3K AKT ERBB2/HER-2 PTEN

Tandem duplications causing gene fusion of BRAF About 2 Mb BRAF KIAA1549 tandem duplication BRAF KIAA-BRAF Astrocytomas KIAA1549 BRAF fusion

Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA take home message 3: PIP3 AKT same gene can be mutated in multiple PTEN ways ERBB2/HER-2

Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor both fused by translocation (rarely) PI3KCA PIP3 AKT ERBB2/HER-2 PTEN

Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor Amplified in brain tumours PI3KCA PIP3 AKT PTEN ERBB2/HER-2 Amplified in breast

What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion -> Small-scale changes - Deletion - Inversion - Duplication - Amplification - Chromosome translocation Large-scale changes

The first human cancer mutation: The Philadelphia chromosome translocation

Philadelphia chromosome 9:22 9:22 reciprocal translocation of chronic myeloid leukaemia fuses BCR to ABL 22:9

BCR-ABL fusion protein Abl is a tyrosine kinase, controlled by N-terminal domain N-term ABL kinase Normal Abl BCR BCR Normal Bcr likes to form dimers Tyrosine kinases are activated by dimerisation BCR BCR ABL kinase -> Activated tyrosine kinase ABL kinase Iconic translocation; diagnostic of CML; target for drug Glivec/Gleevec

There are fusion genes in common epithelial cancers

There are fusion genes in common epithelial cancers TMPRSS2-ERG ~50% prostate cancers Chr. 21 TMPRSS2 ERG Deletion TMPRSS2- ERG fusion

There are fusion genes in common epithelial cancers TMPRSS2-ERG ~50% prostate cancers promoter only (intact) transcription factor TMPRSS2- ERG fusion

Rearrangement more often INactivates a gene A rearrangement can inactivate a gene, - by breaking it or - by gene loss

Don t forget epigenetics! Examples of genes silenced by DNA methylation: Gene Function Cancer MLH1 mismatch DNA repair colorectal Cadherin E cell-cell adhesion lobular breast cell membrane adherens junction Cadherin Cadherin beta-catenin beta-catenin

Viruses e.g. several viruses encode proteins that block p53 and Rb: Human papillomavirus(es) (HPVs) proteins E6, E7 Adenovirus E1a, E1b

and hot topic LINE-1 retrotransposons? We know even less, but LINE1 retrotransposons form 10-1000 new insertions in some tumours can interrupt genes and turn genes on so far one inactivation of APC reported watch this space!